Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: A Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study

British Journal of Haematology

Volumn 159, Issue 5, 2012, Pages 599-613

  Peyrouze, Pauline ^a   Guihard, Soizic ^a   Grardel, Nathalie ^b   Berthon, Céline ^b   Pottier, Nicolas ^c   Pigneux, Arnaud ^d   Cahn, Jean Yves ^e   Béné, Marie Christine ^f   Lhéritier, Véronique ^g   Delabesse, Eric ^h   MacIntyre, Elizabeth ⁱ   Thomas, Xavier ^g   Dombret, Hervé ^j   Ifrah, Norbert ^k   Cheok, Meyling ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c France Institut Pasteur de Lille   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f CHU NANCY BRABOIS   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h CHU PURPAN   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Incidence of acute lymphoblastic leukaemia; Single nucleotide polymorphism

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARID58 GENE; CANCER RISK; CDKN2A GENE; CEBPE GENE; CHROMOSOME DELETION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC MARKER; GENETIC RISK; HUMAN; IKZF1 GENE; LETTER; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84869084407     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12063     Document Type: Letter

References (10)

1. Downing, J.R. & Shannon, K.M. (2002) Acute leukemia: a pediatric perspective. Cancer Cell, 2, 437-445.
2. Faderl, S., O'Brien, S., Pui, C.H., Stock, W., Wetzler, M., Hoelzer, D. & Kantarjian, H.M. (2010) Adult acute lymphoblastic leukemia: concepts and strategies. Cancer, 116, 1165-1176.
3. Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., Vernant, J.P., Lafage-Pochitaloff, M., Chassevent, A., Lheritier, V., Macintyre, E., Bene, M.C., Ifrah, N. & Dombret, H. (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. Journal of Clinical Oncology, 27, 911-918.
4. Papaemmanuil, E., Hosking, F.J., Vijayakrishnan, J., Price, A., Olver, B., Sheridan, E., Kinsey, S.E., Lightfoot, T., Roman, E., Irving, J.A., Allan, J.M., Tomlinson, I.P., Taylor, M., Greaves, M. & Houlston, R.S. (2009) Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nature Genetics, 41, 1006-1010.
5. Prasad, R.B., Hosking, F.J., Vijayakrishnan, J., Papaemmanuil, E., Koehler, R., Greaves, M., Sheridan, E., Gast, A., Kinsey, S.E., Lightfoot, T., Roman, E., Taylor, M., Pritchard-Jones, K., Stanulla, M., Schrappe, M., Bartram, C.R., Houlston, R.S., Kumar, R. & Hemminki, K. (2010) Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukaemia of childhood. Blood, 115, 1765-1767.
6. Pui, C.H., Robison, L.L. & Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030-1043.
7. Sherborne, A.L., Hosking, F.J., Prasad, R.B., Kumar, R., Koehler, R., Vijayakrishnan, J., Papaemmanuil, E., Bartram, C.R., Stanulla, M., Schrappe, M., Gast, A., Dobbins, S.E., Ma, Y., Sheridan, E., Taylor, M., Kinsey, S.E., Lightfoot, T., Roman, E., Irving, J.A., Allan, J.M., Moorman, A.V., Harrison, C.J., Tomlinson, I.P., Richards, S., Zimmermann, M., Szalai, C., Semsei, A.F., Erdelyi, D.J., Krajinovic, M., Sinnett, D., Healy, J., Gonzalez, N.A., Kawamata, N., Ogawa, S., Koeffler, H.P., Hemminki, K., Greaves, M. & Houlston, R.S. (2010) Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nature Genetics, 42, 492-494.
8. Trevino, L.R., Yang, W., French, D., Hunger, S.P., Carroll, W.L., Devidas, M., Willman, C., Neale, G., Downing, J., Raimondi, S.C., Pui, C.H., Evans, W.E. & Relling, M.V. (2009) Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nature Genetics, 41, 1001-1005.
9. Xu, H., Cheng, C., Devidas, M., Pei, D., Fan, Y., Yang, W., Neale, G., Scheet, P., Burchard, E.G., Torgerson, D.G., Eng, C., Dean, M., Antillon, F., Winick, N.J., Martin, P.L., Willman, C.L., Camitta, B.M., Reaman, G.H., Carroll, W.L., Loh, M., Evans, W.E., Pui, C.H., Hunger, S.P., Relling, M.V. & Yang, J.J. (2012) ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 30, 751-757.
10. Yang, W., Trevino, L.R., Yang, J.J., Scheet, P., Pui, C.H., Evans, W.E. & Relling, M.V. (2010) ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia, 24, 894-896.